HEADER TRANSCRIPTION 22-JUL-13 4LSJ TITLE CRYSTAL STRUCTURE OF THE GLUCOCORTICOID RECEPTOR LIGAND BINDING DOMAIN TITLE 2 BOUND TO A DIBENZOXAPINE SULFONAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOCORTICOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: STEROID-BINDING REGION, RESIDUES 522-777; COMPND 5 SYNONYM: GR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: D30 PEPTIDE; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C1, GRL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: D30 SYNTHETIC PEPTIDE KEYWDS NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR M.CARSON,J.G.LUZ,D.CLAWSON,M.COGHLAN REVDAT 3 28-FEB-24 4LSJ 1 REMARK SEQADV REVDAT 2 12-MAR-14 4LSJ 1 JRNL REVDAT 1 29-JAN-14 4LSJ 0 JRNL AUTH M.W.CARSON,J.G.LUZ,C.SUEN,C.MONTROSE,R.ZINK,X.RUAN,C.CHENG, JRNL AUTH 2 H.COLE,M.D.ADRIAN,D.T.KOHLMAN,T.MABRY,N.SNYDER,B.CONDON, JRNL AUTH 3 M.MALETIC,D.CLAWSON,A.PUSTILNIK,M.J.COGHLAN JRNL TITL GLUCOCORTICOID RECEPTOR MODULATORS INFORMED BY JRNL TITL 2 CRYSTALLOGRAPHY LEAD TO A NEW RATIONALE FOR RECEPTOR JRNL TITL 3 SELECTIVITY, FUNCTION, AND IMPLICATIONS FOR STRUCTURE-BASED JRNL TITL 4 DESIGN. JRNL REF J.MED.CHEM. V. 57 849 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24446728 JRNL DOI 10.1021/JM401616G REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 11472 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.790 REMARK 3 FREE R VALUE TEST SET COUNT : 1008 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.57 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.71 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2675 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1889 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2432 REMARK 3 BIN R VALUE (WORKING SET) : 0.1838 REMARK 3 BIN FREE R VALUE : 0.2399 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.08 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 243 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2065 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 50 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.51990 REMARK 3 B22 (A**2) : 9.02770 REMARK 3 B33 (A**2) : -6.50780 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.248 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.407 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.897 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2262 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3069 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 779 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 70 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 321 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2262 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 281 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2737 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.73 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.63 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4LSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000081031. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : KOHZU HLD-4 DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11516 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 139.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PROPANE PH 5.5, 0.3 M REMARK 280 MAGNESIUM FORMATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 294.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 19.48100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 69.69900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.48100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 69.69900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -59.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 520 REMARK 465 LEU A 521 REMARK 465 PRO A 522 REMARK 465 ALA A 523 REMARK 465 THR A 524 REMARK 465 LEU A 525 REMARK 465 LYS A 703 REMARK 465 ARG A 704 REMARK 465 GLU A 705 REMARK 465 GLY A 706 REMARK 465 ASN A 707 REMARK 465 SER A 708 REMARK 465 SER A 709 REMARK 465 GLN A 710 REMARK 465 HIS B -1 REMARK 465 ALA B 10 REMARK 465 THR B 11 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 644 CG CD CE NZ REMARK 470 ASN A 759 CG OD1 ND2 REMARK 470 LYS A 777 CG CD CE NZ REMARK 470 ARG B 2 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 616 -11.47 69.53 REMARK 500 ASP A 742 96.20 -67.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LSJ A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LSJ A 802 DBREF 4LSJ A 522 777 UNP P04150 GCR_HUMAN 522 777 DBREF 4LSJ B -1 11 PDB 4LSJ 4LSJ -1 11 SEQADV 4LSJ SER A 520 UNP P04150 EXPRESSION TAG SEQADV 4LSJ LEU A 521 UNP P04150 EXPRESSION TAG SEQADV 4LSJ TYR A 602 UNP P04150 PHE 602 ENGINEERED MUTATION SEQADV 4LSJ GLY A 638 UNP P04150 CYS 638 ENGINEERED MUTATION SEQRES 1 A 258 SER LEU PRO ALA THR LEU PRO GLN LEU THR PRO THR LEU SEQRES 2 A 258 VAL SER LEU LEU GLU VAL ILE GLU PRO GLU VAL LEU TYR SEQRES 3 A 258 ALA GLY TYR ASP SER SER VAL PRO ASP SER THR TRP ARG SEQRES 4 A 258 ILE MET THR THR LEU ASN MET LEU GLY GLY ARG GLN VAL SEQRES 5 A 258 ILE ALA ALA VAL LYS TRP ALA LYS ALA ILE PRO GLY PHE SEQRES 6 A 258 ARG ASN LEU HIS LEU ASP ASP GLN MET THR LEU LEU GLN SEQRES 7 A 258 TYR SER TRP MET TYR LEU MET ALA PHE ALA LEU GLY TRP SEQRES 8 A 258 ARG SER TYR ARG GLN SER SER ALA ASN LEU LEU CYS PHE SEQRES 9 A 258 ALA PRO ASP LEU ILE ILE ASN GLU GLN ARG MET THR LEU SEQRES 10 A 258 PRO GLY MET TYR ASP GLN CYS LYS HIS MET LEU TYR VAL SEQRES 11 A 258 SER SER GLU LEU HIS ARG LEU GLN VAL SER TYR GLU GLU SEQRES 12 A 258 TYR LEU CYS MET LYS THR LEU LEU LEU LEU SER SER VAL SEQRES 13 A 258 PRO LYS ASP GLY LEU LYS SER GLN GLU LEU PHE ASP GLU SEQRES 14 A 258 ILE ARG MET THR TYR ILE LYS GLU LEU GLY LYS ALA ILE SEQRES 15 A 258 VAL LYS ARG GLU GLY ASN SER SER GLN ASN TRP GLN ARG SEQRES 16 A 258 PHE TYR GLN LEU THR LYS LEU LEU ASP SER MET HIS GLU SEQRES 17 A 258 VAL VAL GLU ASN LEU LEU ASN TYR CYS PHE GLN THR PHE SEQRES 18 A 258 LEU ASP LYS THR MET SER ILE GLU PHE PRO GLU MET LEU SEQRES 19 A 258 ALA GLU ILE ILE THR ASN GLN ILE PRO LYS TYR SER ASN SEQRES 20 A 258 GLY ASN ILE LYS LYS LEU LEU PHE HIS GLN LYS SEQRES 1 B 13 HIS SER SER ARG LEU TRP GLU LEU LEU MET GLU ALA THR HET LSJ A 801 31 HET LSJ A 802 31 HETNAM LSJ N-{3-[(1Z)-1-(10-METHOXYDIBENZO[B,E]OXEPIN-11(6H)- HETNAM 2 LSJ YLIDENE)PROPYL]PHENYL}METHANESULFONAMIDE FORMUL 3 LSJ 2(C25 H25 N O4 S) FORMUL 5 HOH *50(H2 O) HELIX 1 1 PRO A 530 GLU A 540 1 11 HELIX 2 2 PRO A 553 ALA A 580 1 28 HELIX 3 3 GLY A 583 LEU A 587 5 5 HELIX 4 4 HIS A 588 SER A 616 1 29 HELIX 5 5 GLN A 632 MET A 634 5 3 HELIX 6 6 LEU A 636 GLN A 657 1 22 HELIX 7 7 SER A 659 LEU A 672 1 14 HELIX 8 8 SER A 682 VAL A 702 1 21 HELIX 9 9 TRP A 712 ASP A 742 1 31 HELIX 10 10 PRO A 750 ILE A 761 1 12 HELIX 11 11 PRO A 762 GLY A 767 1 6 HELIX 12 12 SER B 1 GLU B 9 1 9 SHEET 1 A 2 LEU A 620 ALA A 624 0 SHEET 2 A 2 LEU A 627 ASN A 630 -1 O ILE A 629 N LEU A 621 SHEET 1 B 2 SER A 674 PRO A 676 0 SHEET 2 B 2 ILE A 769 LYS A 771 -1 O LYS A 770 N VAL A 675 CISPEP 1 GLN A 776 LYS A 777 0 0.53 SITE 1 AC1 13 LEU A 563 ASN A 564 GLN A 570 MET A 601 SITE 2 AC1 13 MET A 604 LEU A 608 PHE A 623 MET A 639 SITE 3 AC1 13 LEU A 732 TYR A 735 CYS A 736 THR A 739 SITE 4 AC1 13 PHE A 749 SITE 1 AC2 7 LEU A 532 PRO A 582 ASN A 586 LEU A 685 SITE 2 AC2 7 THR A 692 TRP A 712 TYR A 716 CRYST1 38.962 139.398 48.068 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025707 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007174 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020790 0.00000